Clinical Implications of Genetic Testing in Hypertrophic Cardiomyopathy

Clinical Implications of Genetic Testing in Hypertrophic Cardiomyopathy

Presenters: Dr. Anjali Owens, Dr. Sharon Cresci
Moderator: Dr. James Udelson

Summary: It is estimated that 1 in every 500 adults living in the U.S. have HCM, but a large percentage of patients are undiagnosed. Which of your patients is undiagnosed? Hypertrophic Cardiomyopathy (HCM) is the most common form of genetic heart disease and can affect people of any age. HCM can be a debilitating and life-changing disease. People with HCM are often forced to make lifestyle changes, such as limiting their activity, to accommodate their disease. Sometimes this accommodation might not even be noticed by the patient themselves meaning careful questioning of symptoms and changes in activity are critical.

Learn more about HCM in this free webinar so you are better able to discuss its impact with your patients.

Anjali Owens MD

Anjali Tiku Owens, MD
Assistant Professor of Medicine
University of Pennsylvania

Sharon Cresci MD

Sharon Cresci, MD, FAHA, FACC, FASE
Washington University, Cardiovascular Division
Associate Professor of Medicine
Associate Professor of Genetics

James Udelson MD FAHA

Dr. James E. Udelson, MD, FAHA
Chief, Division of Cardiology,
Tufts Medical Center